您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Niclosamide monohydrate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Niclosamide monohydrate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Niclosamide monohydrate图片
CAS NO:73360-56-2
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
氯硝柳胺一水合物
BAY2353 monohydrate
产品介绍
Niclosamide (BAY2353) monohydrate 是一种具有口服活性的用于寄生虫感染研究的抗蠕虫化合物。Niclosamide monohydrate 是STAT3抑制剂,在 HeLa 细胞中的IC50为 0.25 μM。Niclosamide monohydrate 具有抗癌的生物活性,并能抑制 Vero E6 细胞的 DNA 复制。
生物活性

Niclosamide (BAY2353) monohydrate is an orally active antihelminthic agent used in parasiticinfectionresearch[1]. Niclosamide monohydrate is aSTAT3inhibitor with anIC50of 0.25 μM in HeLa cells[4]. Niclosamide monohydrate has biological activities againstcancer, and inhibits DNA replication in Vero E6 cells[2][3][5].

IC50& Target[1]

STAT3

0.25 μM (IC50, in HeLa cells)

体外研究
(In Vitro)

Niclosamide monohydrate (0.6 nM-46 μM) treatment inhibits adrenocortical carcinoma cellular proliferation in BD140A, SW-13, and NCI-H295R cells[3].
Niclosamide monohydrate (0.05-5 μM, 24 h) treatment inhibits STAT3-mediated luciferase reporter activity in HeLa cells[4].
Niclosamide monohydrate (10 μM) treatment inhibits virus replication in Vero E6 cells[5].

Cell Viability Assay[3]

Cell Line:BD140A, SW-13 and NCI-H295R cells
Concentration:0.6 nM-46 μM
Incubation Time:
Result:Inhibited cellular proliferation in adrenocortical carcinoma cell lines with the IC50of 0.12 μM, 0.15 μM, and 0.53 μM in BD140A, SW-13, and NCI-H295R, respectively.

Cell Viability Assay[4]

Cell Line:Hela cells
Concentration:0.05-5 μM
Incubation Time:24 hours
Result:Inhibited STAT3-mediated luciferase reporter activity with an IC50of 0.25 μM.

Cell Viability Assay[5]

Cell Line:Vero E6 cells
Concentration:10 μM
Incubation Time:2 days
Result:Inhibited the synthesis of viral antigens of SARS-CoV in Vero E6 cells.
体内研究
(In Vivo)

Niclosamide monohydrate (oral gavage; 100 mg/kg, 200 mg/kg; once a week; 8 weeks) treatment inhibits adrenocortical carcinoma tumor growth in vivo[3].

Animal Model:Nu+/Nu+mice injected with NCI-H295R cells[3]
Dosage:100 mg/kg, 200 mg/kg
Administration:Oral gavage; 100 mg/kg, 200 mg/kg; once a week; 8 weeks
Result:Showed a 60%-80% inhibition in tumor growth, as compared to the control group.
Clinical Trial
分子量

345.13

Formula

C13H10Cl2N2O5

CAS 号

73360-56-2

中文名称

氯硝柳胺一水合物

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.